ASX News Health Care Cleo kicks off long path towards FDA approval for ovarian cancer blood tests Cleo Diagnostics has announced it's commenced the FDA regulatory process to get into the US market… 1 min26 June 2024 09:55 (AEDT)
ASX News Health Care Cleo Diagnostics reports its ovarian cancer blood tests superior to ultrasound Nine moths after listing on the ASX, Cleo Diagnostics (ASX:COV) has made its first major biotech breakthrough. 2 mins29 May 2024 10:36 (AEDT)